Authors


Brent Kleintop

Latest:

Perspectives on Quality Attributes of Drug Products Containing Nanomaterials

In this article, the contents of a stimulus article produced by the joint subcommittee of the USP Expert Committees on Dosage Forms, Physical Analysis, and Excipients and relevant comments from a workshop session are summarized.


LakshmiDevi Ethirajan

Latest:

Multilayer Tablets: A Piece Of Cake?

Multilayer tablets: A piece of cake or just a passing fad? We bring experts together to find out.


Robert R. Reich

Latest:

The Adverse Effects of Cellulosic Material in Isolator Barrier Technology

The authors focus on the effects of cellulosic materials during the performance qualification validation of a transfer barrier isolator used for the purpose of sterility testing.


Ruggero Bettini

Latest:

Validation of a Clean-in-Place System on a Capsule Filling Machine

The aim of this study was to validate the automated clean-in-place (CIP) system installed on a capsule filling machine to determine its ability to adequately eliminate contaminants. The results obtained from the proposed cleaning validation trial showed that all the soluble tracer was removed after the washing procedure. At the end of the CIP procedure, the discharged water had the same pH, phosphate content and total organic content as the supplied water. Lack of cross-contamination in the product was also demonstrated and a recovery trial highlighted the complete elimination of the tracer from the machine.


Andy Rignall

Latest:

Evaluating Progress in Analytical Quality by Design

The authors present the results of a survey of small- and large-molecule pharmaceutical and biopharmaceutical companies on implementation of Analytical quality by design concepts.


Christopher Allen

Latest:

Future Hub of Biotech: Boston or San Francisco?

San Francisco and Boston sit on opposite coasts and each has a rich history and character that make them distinct. However, they share some similarities: both cities are centers of top biotechnology hubs in the US.


Eric Bohn

Latest:

Fundamentals of GMP Warehouse Design

Storage and retrieval methods and the unique requirements found in building codes are crucial considerations.


Trevor J. Hallam

Latest:

Industrializing Design, Development, and Manufacturing of Therapeutic Proteins

The authors discuss various approaches and related issues, including production of difficult-to express proteins using cell-free expression systems, scalability of protein expression, and site-specific chemical modifications.


Fadi Abou-Shakra

Latest:

Rapid Screening for Elemental Impurities using ICP-MS

The authors describe a rapid, single-point calibration approach for ICP–MS analysis of raw materials used in drug product manufacturing.


Mark L. Balboni

Latest:

Process Analytical Technology Concepts and Principles

This article outlines the key concepts that define process analytical technology and emphasizes the relevant theory and applications of chemometrics.


James S. McElvain

Latest:

Early Development GMPs for Small-Molecule Specifications: An Industry Perspective (Part V)

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.


Marcus Behrens

Latest:

Multilayer Tablets: A Piece Of Cake?

Multilayer tablets: A piece of cake or just a passing fad? We bring experts together to find out.



Harold Rode

Latest:

Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process Considerations

USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.


Jill H. Kaufman

Latest:

Emerging Life Sciences Standards

This article looks at some of the current and emerging standards that are shaping the life sciences industry, and how pharma and biotech companies can benefit by implementing them.


Parenteral Drug Association

Latest:

Parenteral Drug Association (PDA)

PDA is the leading global provider of science, technology, regulatory information, and education for the bio/pharmaceutical community.


Doug Kirsch

Latest:

Press Adjustments Help Prevent Tableting Problems

Adjusting the tablet press and its systems can prevent manufacturing and product quality problems.



Ivo Eggen

Latest:

Control Strategies for Synthetic Therapeutic Peptide APIs Part III: Manufacturing Process Considerations

USP's Therapeutic Peptides Expert Panel discusses manufacturing processes and impurity control for synthetic peptide APIs.


Nichola Stevens

Latest:

The Validation and Implementation of a Chromatography Data System

This article describes the approach used to upgrade a chromatography data system. The upgrade was required to meet the current regulatory requirements for good laboratory and good manufacturing practice. Compliance with 21 CFR Part 11 for electronic records and electronic signatures was also a major consideration. The procedures used for this project followed the software development life cycle (SDLC) and involved the co-ordination of personnel from the software vendor, the user department, information technology and quality assurance.


Anita Szajek

Latest:

Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?

The global supply chain for bovine and porcine heparin and regulatory considerations are examined.


Mesbah Uddin Talukder

Latest:

The Development of a Floating Drug-Delivery System for Metronidazole

The authors developed a metronidazole-based floating drug-delivery system to investigate the effect of rate-controlling polymers on release pattern and duration of buoyancy in matrix tablets.


Thomas F. Curry

Latest:

Application of the Weisberg t-test for Outliers

Determining whether a data point is an "outlier" - a result that does not fit, is too high or too low, is extreme or discordant - is difficult when using small data sets, such as the data from three, four or five conformance runs. In this article, the authors demonstrate that the Weisberg t-test is a powerful tool for detecting deviations in small data sets.


Dr Ajay Gupta

Latest:

Fixed-Dose Combinations

Fixed-dose combinations (FDCs) reduce the number of pills that must be taken, but they have also been a topic of concern, mainly because of the perceived potential for increased adverse events. PTE speaks with researchers to explore the benefits and concerns of FDCs.


Z. Jessica Tan

Latest:

Early Development GMPs for Stability (Part IV)

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development, with a focus on stability.


Jun Wang

Latest:

A New Approach to Forced Degradation Studies Using Anhydrous Conditions

In this article, the authors demonstrate that a normal-phase chromatographic method was stability-indicating for a water-sensitive prodrug. The stress conditions using aqueous and non-aqueous conditions were also compared to understand the information obtained with each approach.


Susanne Keitel

Latest:

Significant Revisions and Updates to the European Pharmacopoeia

Revisions and updates for the 9th Edition of the European Pharmacopoeia result in changes to more than half of the content.


Mark Leykin

Latest:

Single-Use Technology in Parenteral Fill/Finish

Application of single-use technology in a parenteral facility for syringe filling.


Kate Achtien

Latest:

ZFN Technology Advances Biopharmaceutical Manufacturing

Applications of ZFN technology in biopharmaceutical cell-line engineering.


Geoff Carr

Latest:

Black Specks in Tablet Stability Samples

A study of root cause in stability samples suggests the need for tighter control of the sodium lauryl sulfate manufacturing processes.